Skip to content

The new way prosecutors are using an old act

And how it's affecting drug CEOs

[jwp-video n="1"]

As the effects of the opioid crisis are felt across the country, federal prosecutors are taking action and prosecuting CEOs of pharmaceutical companies. The Controlled Substance Act is one of their most novel weapons. 

Watch as CQ Roll Call’s senior multimedia producer Jinitzail Hernández explains how.  

[jwp-video n=”1″]

Recent Stories

Capitol Ink | Victory parade

Trump surge in blue states added to Dem House headwinds

‘He betrayed us’: Officers who protected the Capitol grapple with Trump’s return

Trump win could prompt US government switch in legal fights

How key results could influence health policy

Trump win opens door to major shift in US immigration policies